EUVIMEDEUVIMED entdecken
Crossref

TLR9–MyD88–TRAF6 signaling mediates mitochondrial DNA–induced systemic inflammatory response after radiofrequency ablation of hepatic hemangioma, with Merlin as a downstream participant

Ruize Gao, Shilun Wu, Beibei Zeng, Ning Li, Jun Gao, Shaohong Wang

International Immunopharmacology · 2026-12 · 190 · 117546

DOI: 10.1016/j.intimp.2026.117546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Ruize Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary Surgery, Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, DNA, Mitochondrial, Liver Neoplasms, Radiofrequency Ablation. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Radiofrequency ablation (RFA) is an effective minimally invasive treatment for hepatic hemangioma, but systemic inflammatory response (SIR) syndrome-associated complications should be considered. This study aimed to explore the mechanism and potential targets in SIR caused by RFA of hepatic hemangioma. METHODS: Murine orthotopic hepatic hemangioma model with RFA treatment and heme-stimulated human lung microvascular endothelial cells (HLMVECs) were utilized for investigations. Colocalization staining was conducted to observe mitochondrial DNA (mtDNA) oxidation damage and the colocalization of TLR9, MyD88 and TRAF6. Co-IP was conducted to test the interactions among TLR9, TRAF6 and MyD88. Inflammatory cytokines were detected by ELISA. VBIT-4 was utilized to inhibit the release of mtDNA. RESULTS: Along with the SIR caused by RFA, there are mitochondrial swelling and damage, increased release of mtDNA and increased TLR9 expression. Inhibiting mtDNA release using VBIT-4, generation of inflammatory cytokines IL-1β, IL-18, IL-6 and TNF-α significantly reduced and TLR9 expression was reduced. Further rescue experiment by overexpressing TLR9 counteracted the inhibition role of VBIT-4 pretreatment on inflammatory cytokines generation. In hepatic hemangioma mice with RFA treatment, injection of sh-TLR9 could alleviate the development of SIR, manifested as markedly reduced inflammatory cells (lymphocyte, monocyte and neutrophil) and inflammatory cytokines. Mechanistically, TLR9 interacted with MyD88 and TRAF6, and TLR9 silencing attenuated the SIR in association with the changes of Merlin phosphorylation. CONCLUSION: This study demonstrated the involvements of mtDNA/TLR9 mediated inflammatory response in SIR of hepatic hemangioma following RFA. Targeting TLR9 might be an available strategy to prevent SIR in RFA of hepatic hemangioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 9DNA, MitochondrialLiver NeoplasmsRadiofrequency AblationHemangiomaSystemic Inflammatory Response SyndromeAnimalsTNF Receptor-Associated Factor 6HumansMyeloid Differentiation Factor 88Signal TransductionMiceCytokinesMaleMice, Inbred C57BL

Stichwörter der Autor:innen

MerlinMitochondrial DNARadiofrequency ablationSystemic inflammatory responseToll-like receptor-9

Substanzen

Toll-Like Receptor 9DNA, MitochondrialTNF Receptor-Associated Factor 6Myeloid Differentiation Factor 88Tlr9 protein, mouseCytokinesMyd88 protein, mouse

Autor:innen und Institutionen

  • Division of Hepatobiliary Surgery, Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China.
  • Department of Pathology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China.
  • Division of Hepatobiliary Surgery, Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China. Electronic address: shaohong.wang@ccmu.edu.cn.

Förderung

  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Gao, R., Wu, S., Zeng, B., Li, N., Gao, J., & Wang, S. (2026). TLR9–MyD88–TRAF6 signaling mediates mitochondrial DNA–induced systemic inflammatory response after radiofrequency ablation of hepatic hemangioma, with Merlin as a downstream participant. International Immunopharmacology, 190, 117546. https://doi.org/10.1016/j.intimp.2026.117546

Vancouver

Gao R, Wu S, Zeng B, Li N, Gao J, Wang S. TLR9–MyD88–TRAF6 signaling mediates mitochondrial DNA–induced systemic inflammatory response after radiofrequency ablation of hepatic hemangioma, with Merlin as a downstream participant. International Immunopharmacology. 2026;190:117546. doi:10.1016/j.intimp.2026.117546

BibTeX
@article{Gao2026,
  author = {Gao, Ruize and Wu, Shilun and Zeng, Beibei and Li, Ning and Gao, Jun and Wang, Shaohong},
  title = {TLR9–MyD88–TRAF6 signaling mediates mitochondrial DNA–induced systemic inflammatory response after radiofrequency ablation of hepatic hemangioma, with Merlin as a downstream participant},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {190},
  pages = {117546},
  doi = {10.1016/j.intimp.2026.117546}
}
Kostenlos starten →